Remedium Lifecare
Ticker >

Remedium Lifecare share price

Remedium Lifecare Ltd.

BSE: 539561 SECTOR: Trading  22k   69   5

109.70
-0.10 (-0.09%)
BSE: Today, 03:33 PM

Price Summary

Today's High

₹ 111

Today's Low

₹ 109

52 Week High

₹ 179.66

52 Week Low

₹ 50.72

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 1105.78 Cr.

Enterprise Value

₹ 1083.92 Cr.

No. of Shares

10.08 Cr.

P/E

14.59

P/B

12.17

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  9.02

CASH

₹ 21.86 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

1.11 %

EPS (TTM)

₹  7.52

Sales Growth

1%

ROE

70.92 %

ROCE

102.54%

Profit Growth

403.44 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year1%
3 Year460.82%
5 Year329.16%

Profit Growth

1 Year403.44%
3 Year169.57%
5 Year231.28%

ROE%

1 Year70.92%
3 Year36.25%
5 Year23.53%

ROCE %

1 Year102.54%
3 Year42.7%
5 Year27.97%

Debt/Equity

0

Price to Cash Flow

53.94

Interest Cover Ratio

17.4611618072557

CFO/PAT (5 Yr. Avg.)

2.93051696150989

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 1.11 0
Dec 2023 1.11 0
Sep 2023 1.11 0
Jun 2023 1.11 0
Mar 2023 1.11 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 169.568623755403% for the Past 3 years.
  • The company has shown a good revenue growth of 460.824376916904% for the Past 3 years.
  • Company has been maintaining healthy ROE of 36.2502729777856% over the past 3 years.
  • Company has been maintaining healthy ROCE of 42.6960408621877% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 17.4611618072557.
  • Company’s PEG ratio is 0.0361738158608017.
  • The company has an efficient Cash Conversion Cycle of 40.1012850435339 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.93051696150989.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 116.138379234684.

 Limitations

  • The company has a low EBITDA margin of -5.43871419411296% over the past 5 years.
  • The company is trading at a high PE of 14.59.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 176.48 75.58 330.47 468.57 1834.18
Total Expenditure 174.95 78.48 323.18 462.23 1779.48
Operating Profit 1.53 -2.9 7.28 6.34 54.7
Other Income 0.02 0.1 0 4.08 14.12
Interest 0.02 0 0 0 0.03
Depreciation 0.01 0.01 0.01 0.02 0.01
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.52 -2.81 7.27 10.41 68.78
Tax 0 1.97 2.02 3.88 0
Profit After Tax 1.52 -4.78 5.25 6.53 68.78
Adjusted EPS (Rs) 0.15 -0.47 0.52 0.65 6.82

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 0.16 2.89 90.03 504.79 509.84
Total Expenditure 0.23 2.5 89.31 502.98 502.67
Operating Profit -0.07 0.39 0.72 1.82 7.17
Other Income 0.09 0.01 0.01 0.01 0.83
Interest 0 0.01 0.02 0.23 0.45
Depreciation 0 0.01 0.06 0.07 0.15
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.02 0.38 0.65 1.53 7.4
Tax 0.01 0.1 0.17 0.45 1.97
Net Profit 0.01 0.28 0.48 1.08 5.43
Adjusted EPS (Rs.) 0 0.03 0.05 0.11 0.54

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 3.6 3.6 3.6 3.6 3.6
Total Reserves -0.52 -0.25 0.26 1.34 6.76
Borrowings 0.08 0.36 10.5 0 0
Other N/C liabilities 0 0 0 0 -0.01
Current liabilities 0.37 0.55 24.17 218.82 1143.86
Total Liabilities 3.53 4.27 38.53 223.76 1154.22
Assets
Net Block 0 0.23 0.21 0.19 0.08
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 3.53 4.04 38.32 223.57 1154.14
Total Assets 3.53 4.27 38.53 223.76 1154.22
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 0.01 0.38 0.65 1.53 7.4
Adjustment -0.09 0.01 0.06 0.18 0.19
Changes in Assets & Liabilities 0 -0.59 -10.89 10.03 14.89
Tax Paid 0.01 0 -0.04 -0.45 -1.98
Operating Cash Flow -0.07 -0.2 -10.21 11.28 20.5
Investing Cash Flow 1.06 -0.24 -0.04 -0.05 -0.04
Financing Cash Flow 0.08 0.29 10.14 -10.61 -0.04
Net Cash Flow 1.06 -0.15 -0.11 0.62 20.42

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 1.11 1.11 1.11 1.11 1.11
siddharth chimanlal shah 1.11 1.11 1.11 1.11 1.11
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 98.89 98.89 98.89 98.89 98.89
achintya securities priva... - - - - 1.53
alok ashok tiwari 1.73 1.73 1.59 1.59 1.59
amit prakash masalia 1.89 1.89 1.89 1.89 1.89
chirag narendra modh 3.81 4.20 4.20 4.20 4.20
cnm finvest private limit... 5.45 5.45 5.45 5.45 4.59
deena prakash masalia 1.81 1.81 1.81 1.81 1.81
dhansukhbhai champaklal j... 2.64 2.64 2.64 2.64 2.64
guruprasad sitaram kudva 1.46 1.46 1.46 1.46 1.19
jayashree d singh 1.60 1.60 1.60 1.60 1.60
jiteshkumar shashikantbha... 2.78 2.78 2.78 2.78 2.78
jyotika deepak shenoy 6.52 6.54 5.55 5.26 3.19
kamlesh pravinchandra sha... 1.33 1.33 1.29 - 1.09
kamlesh pravinchandra sha... 2.50 2.45 2.29 2.14 1.39
lalit kumar lalwani - - - 1.79 1.63
maryam maqbool dhoki 1.94 1.94 1.94 1.94 1.94
mukesh kumar naresh 1.62 1.62 1.62 1.62 1.62
padmavathy kaimal kondath... 1.46 1.46 1.46 1.46 1.59
payal amit masalia 1.78 1.78 1.78 1.78 1.78
radhika vasanth - 1.14 1.14 - 1.04
sadhana santhosh shanbhag... 1.11 1.11 1.11 - 1.06
sathish s nayak 3.71 3.78 3.78 3.78 3.42
sheela rajendrakumar kaim... - - - - 1.69
sudhakar jha 1.60 1.60 - - 1.60
tulsi arvindakshan nair - - - 1.47 1.18
uppinangady sudhindra nay... 8.11 8.10 7.94 - 7.47
vasanth kumar bantwal 1.67 1.67 1.67 1.67 1.55
venkatesh bhaskar shenoy 3.98 3.98 3.99 3.99 3.23
vignesh - - - 5.69 5.94
vishek . masalia 1.13 2.95 2.95 - 2.95
achinya securities privat... - - - 1.31 -
kamlesh pravinchandra - - - 1.24 -
kapil mahesh kothari 1.40 1.40 1.40 1.00 -
minal uday doshi 1.09 1.09 1.08 1.07 -
radhika vasanth 1.14 - - 1.14 -
sadhana santhosh - - - 1.11 -
sheela rajendra kaimal 1.47 1.47 1.47 1.47 -
uppinangady sudhindra - - - 7.76 -
vishek masalia - - - 2.95 -
lalit kumar lalwani . 1.79 1.79 1.79 - -
remedium escrow suspense ... - - 4.39 - -
tulasi arvindakshan nair 1.47 1.47 1.47 - -
vignesh . - - 5.69 - -
heroic mercantile 1.56 1.15 - - -
vignesh . 5.53 5.69 - - -
prashant y parikh 1.83 - - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Remedium Lifecare informs about certificate6 Apr 2024, 1:55PM Remedium Lifecare informs about compliance certificate6 Apr 2024, 12:45PM Remedium Lifecare gets export order worth Rs 169 crore28 Feb 2024, 11:00AM Remedium Lifecare informs about receipt of export order28 Feb 2024, 9:59AM Remedium Lifecare to acquire manufacturing facility in Hyderabad23 Feb 2024, 11:53AM Remedium Lifecare informs about board meeting 23 Feb 2024, 10:28AM Remedium Lifecare - Quaterly Results14 Feb 2024, 5:08PM Remedium Lifecare - Quaterly Results14 Feb 2024, 5:08PM Remedium Lifecare informs about record date 12 Feb 2024, 10:53AM Remedium Lifecare informs about issuance of duplicate share certificate31 Jan 2024, 10:00AM Remedium Lifecare informs about RTA certificate10 Jan 2024, 2:55PM Remedium Lifecare - Quaterly Results11 Nov 2023, 6:29PM Remedium Lifecare - Quaterly Results11 Nov 2023, 6:29PM Remedium Lifecare informs about certificate21 Oct 2023, 12:29PM Remedium Lifecare informs about resignation of CS cum CO8 Sep 2023, 4:48PM Remedium Lifecare - Quaterly Results12 Aug 2023, 2:54PM Remedium Lifecare - Quaterly Results12 Aug 2023, 2:54PM Remedium Lifecare informs about AGM notice and annual report 27 Jun 2023, 9:55AM Remedium Lifecare informs about AGM 26 Jun 2023, 2:15PM Remedium Lifecare informs about AGM26 Jun 2023, 12:39PM Remedium Lifecare planning to increase borrowing limit by issuance of debt securities15 Jun 2023, 10:22AM Remedium Lifecare - Quaterly Results30 May 2023, 8:14PM Remedium Lifecare - Quaterly Results30 May 2023, 8:14PM Remedium Lifecare informs about compliance certificate19 Apr 2023, 5:06PM Remedium Lifecare informs about newspaper publication 9 Feb 2023, 5:04PM Remedium Lifecare - Quaterly Results7 Feb 2023, 5:49PM Remedium Lifecare - Quaterly Results7 Feb 2023, 5:49PM Remedium Lifecare - Quaterly Results7 Feb 2023, 5:49PM Remedium Lifecare informs about scheme of arrangement17 Dec 2022, 10:23AM Remedium Lifecare gets nod to merge MVK Lifesciences with itself15 Nov 2022, 5:41PM Remedium Lifecare - Quaterly Results4 Nov 2022, 6:44PM Remedium Lifecare - Quaterly Results4 Nov 2022, 6:44PM Remedium Lifecare informs about outcome of 33rd AGM 20 Sep 2022, 3:05PM Remedium Lifecare - Quaterly Results9 Feb 2022, 6:19PM Remedium Lifecare - Quaterly Results9 Feb 2022, 6:19PM Remedium Lifecare informs about 32nd AGM31 Aug 2021, 10:03AM Remedium Lifecare informs about newspaper clippings 12 Jul 2021, 3:43PM Remedium Lifecare informs about disclosure14 Jun 2021, 2:12PM Remedium Lifecare informs about change in registered office address12 May 2021, 1:39PM Remedium Lifecare submits disclosure14 Apr 2021, 1:06PM Remedium Lifecare submits disclosure 10 Apr 2021, 11:27AM Remedium Lifecare inform about disclosure23 Mar 2021, 3:52PM Roxy Exports informs about board meeting11 Jul 2020, 10:53AM Roxy Exports informs about board meeting20 Jun 2020, 11:11AM

Remedium Lifecare Stock Price Analysis and Quick Research Report. Is Remedium Lifecare an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Remedium Lifecare has a PE ratio of 14.5939761600681 which is low and comparatively undervalued .

  • Share Price: - The current share price of Remedium Lifecare is Rs 109.7. One can use valuation calculators of ticker to know if Remedium Lifecare share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Remedium Lifecare has ROA of 0.787548887074305 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Remedium Lifecare has a Current ratio of 1.00898607729768 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Remedium Lifecare has a ROE of 70.9178238849861 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Remedium Lifecare has a D/E ratio of 0 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Remedium Lifecare has an Inventory turnover ratio of 11.1813382868647 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Remedium Lifecare has reported revenue growth of 0.999362311479257 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Remedium Lifecare for the current financial year is 1.40619563209076 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Remedium Lifecare is Rs 0 and the yield is 0 %.

Last Updated on:
Brief about Remedium Lifecare

Remedium Lifecare Limited Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Remedium Lifecare Limited is a leading pharmaceutical company that specializes in the manufacturing and marketing of a wide range of healthcare products. The company was established in [year] and has since grown to become a trusted name in the industry.

Remedium Lifecare Limited: Share Price

The share price of Remedium Lifecare Limited is a key indicator for investors looking to analyze the company's performance in the stock market. Our website provides real-time share price updates, allowing investors to stay informed about the latest market trends.

Remedium Lifecare Limited: Balance Sheet

The balance sheet of Remedium Lifecare Limited offers insights into the company's financial health and stability. Investors can analyze key financial ratios and trends to make informed investment decisions. Our website provides downloadable annual reports that include balance sheets for easy reference.

Remedium Lifecare Limited: Annual Report

The annual report of Remedium Lifecare Limited provides a comprehensive overview of the company's performance over the past year. Investors can delve into details such as revenue growth, profitability, and future outlook. Our website offers downloadable annual reports to facilitate in-depth analysis.

Remedium Lifecare Limited: Dividend

Dividends are an important consideration for long-term stock investors. Remedium Lifecare Limited's dividend payout history can provide insights into the company's profitability and commitment to shareholder returns. Investors can find dividend information on our website, along with dividend history and payout ratios.

Remedium Lifecare Limited: Quarterly Result

Tracking the quarterly results of Remedium Lifecare Limited is crucial for investors. Our website provides access to downloadable quarterly reports, enabling investors to analyze revenue growth, profit margins, and other financial metrics. These reports can help investors assess the company's performance over shorter periods.

Remedium Lifecare Limited: Stock Price

The stock price of Remedium Lifecare Limited fluctuates in response to market conditions, industry trends, and company-specific factors. Investors can monitor the stock price on our website through real-time updates and interactive price charts. These tools assist investors in making informed decisions based on market trends.

Remedium Lifecare Limited: Price Chart

Our website offers interactive price charts that illustrate the historical performance of Remedium Lifecare Limited's stock. Long-term stock investors can analyze price patterns, trends, and volatility to understand the market sentiment around the company's stock. These charts provide valuable insights for investors.

Remedium Lifecare Limited: News and Updates

Stay updated with the latest news and updates about Remedium Lifecare Limited on our website. We curate relevant news articles, press releases, and market updates, ensuring investors have access to the latest information that could impact the company's stock performance.

Remedium Lifecare Limited: Concall Transcripts

Concall transcripts offer a detailed record of management discussions and question-answer sessions during conference calls. Our website provides downloadable concall transcripts for Remedium Lifecare Limited, allowing investors to gain insights into the company's strategy, outlook, and response to market conditions.

Remedium Lifecare Limited: Investor Presentations

Investor presentations provide a snapshot of Remedium Lifecare Limited's business model, strategies, and financial performance. Our website offers downloadable investor presentations that highlight the company's growth plans, competitive advantages, and key industry trends. Investors can use these presentations for a deeper understanding of the company's prospects.

Remedium Lifecare Limited: Promoters

The promoters of Remedium Lifecare Limited play a significant role in driving the company's growth and success. Investors can explore information about the promoters on our website, including their professional backgrounds, involvement in the company, and stakeholding. This information helps investors gauge the commitment and expertise of the company's key stakeholders.

Remedium Lifecare Limited: Shareholders

Understanding the shareholder base of Remedium Lifecare Limited is essential for investors. Our website provides information about major shareholders, institutional investors, and public shareholding. Investors can gain insights into the company's ownership structure and identify potential influencers on stock value and decision-making.

At our website, we offer pre-built screening tools that can help investors analyze Remedium Lifecare Limited's stock based on their preferred parameters. Additionally, premium features such as DCF analysis, BVPS analysis, earnings multiple approach, and DuPont analysis are available to assist investors in calculating fair value and gaining a deeper understanding of the company's financials.

Please note that all downloadable resources, including annual reports, concall transcripts, investor presentations, credit ratings, and research reports, are provided on our website to facilitate comprehensive stock analysis for long-term investors.

Read More
X